tirzepatide vs retatrutide 10mg 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 New Phase 3 clinical results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of Retatrutide or Tirzepatide? Triple vs

While tirzepatide is already approved for the treatment of T2D and chronic weight management, retatrutide is still under investigation in phase 3 clinical trials

Nausea affects approximately 16-25% of retatrutide participants depending on dose, compared to roughly 18% for semaglutide and 17-22% for tirzepatide

It increases hepatic glucose output in the short term, which sounds counterintuitive for a metabolic drug, but the body compensates through increased energy expenditure

Maintain confidence with subtle, refreshed results

Trulicity EPAR Assessment Report (Variation, EMA/585102/2019) pancreatitis and serious adverse events